No major effects of epinephrine on glycogen synthesis and glycolysis by intact Novikoff ascites-hepatoma were noted. However, at 2 \m=x\10\m=-\5 m epinephrine concentration glycogen synthesis from glucose was slightly enhanced and lactic acid production was slightly decreased. These effects were attributed to a stimulation of UDPglucose-\g=a\-glucan glucosyltransferase and an inhibition of phosphofructokinase. Breakdown 
were attributed to a stimulation of UDPglucose-\g=a\-glucan glucosyltransferase and an inhibition of phosphofructokinase. Breakdown of glycogen deposited by the tumour cells was also inhibited to a small extent by epinephrine. The pattern of epinephrine action on glucose metabolism of tumour cells suggests that loss as well as modification of the receptor (of epinephrine) occurs during neoplastic transformation of liver.
Administration of <?///nephrine into animals normally results in the mobilisation of liver and muscle glycogen and elevation of blood sugar level. Sutherland and his coworkers have proposed that membrane bound adenyl cyclase is the primary adrenergic receptor in animal tissues (Robinson et al. 1967 ). Glycogenolytic action of epinephrine is believed to occur in a stepwise manner. First, activation of adenyl cyclase results in increased conversion of ATP into adenosine 3' 5'-phosphate (cyclic AMP**). Cyclic AMP, in turn, augments phosphorylase kinase activity. Activated phosphorylase kinase transforms phosphorylase b (inactive) into phosphorylase a (active) in the presence of ATP and Mg~+ . In consequence, glycogen is broken down by phosphorylase a into glucose 1-phosphate and activation of phosphofructokinase by cyclic AMP (Passonneau Se Lowry 1962) accomplishes transformation of glycogen to lactate along the Embden-Meyerhof pathway. Besides the above sequence for phos¬ phorylase activation increased concentration of phosphorylase a can be ob¬ tained by inhibition of a specific phosphodiesterase (Robinson et al. 1967 ) (which converts cyclic AMP into 5'-AMP) or activation of phosphorylase b by a proteinase in the presence of Ca++ ions (Huston Se Krebs 1968) . In other studies, it has been observed that activation of phosphorylase by epinephrine is followed by inhibition of UDPglucose-a-glucan glucosyltransferase (Belocopitow 1961). Craig Se Lamer (1964) have further shown that epinephrine action results in the decrease of both glucose 6-phosphate dependent (D) and independent (I) forms of UDPglucose-a-glucan glycosyltransferase.
During the course of a study on the glycogen metabolism of Novikoff asciteshepatoma cells, it became apparent that the unusual ability of this tumour to store glycogen (Nigam 1967a) (Nigam 1962 (Nigam 19676) . They were washed once before being used in a metabolic reaction.
Incubation procedure: Tumour cell suspension (0.9 ml) was transferred to 20-ml beakers, fp/nephrine solution (0.1 ml) of desired concentration in 10 mM neutral ascorbic acid solution was added. Control reaction mixtures contained 0.1 ml ascorbic acid solution only. After 5 min of incubation at room temperature, 0.05 ml labelled glucose solution (0.1 m, 50 000 counts/min) was added and the beakers were transferred to a Dubnoff metabolic shaker maintained at 36-3ScC and flushed with 100 Vo oxygen.
The digests were shaken at 10-20 strokes per min. Duplicate digests were usually run and one reaction mixture was used for the isolation of glycogen and the estimation of its !4C and the other for the determination of lactic acid, glucose and sugar phosphates.
Isolation of glycogen: Glycogen was isolated from reaction mixtures by digestion with hot KOH and precipitation with ethanol as described by Robbins et al. (1959) , except that 0.1 ml instead of 0.2 ml saturated sodium sulphate was used for the pre¬ cipitation of glycogen.
Estimation of the radioactivity in glycogen: In most experiments where incorpora¬ tion of glycogen was to be determined 5 mg unlabelled rabbit liver glycogen was added after KOH digestion. The isolated glycogen was dissolved in 2 ml warm distilled water and 1 ml solution was plated on aluminium planchéis (5 cm2 in area) and dried. Radioactivity was measured by using a Picker Nuclear Counter with an ultra thin window. The samples were found to have negligible self absorption in the range of glycogen usually present in the samples (2.5-3.0 mg/ml). It was necessary to correct for absorption due to 0.05 ml saturated sodium sulphate solution present per ml of the sample. It reduced the counts 25 %>. Since all samples contained the same amount of sodium sulphate, the same correction factor was applied to all samples.
Estimation of the amount of glycogen synthesised: The number of micromoles of glucose equivalent of glycogen formed was given by multiplying the c. p. m. in isolated glycogen (after correction for the sodium sulphate effect and the background) by the number of micromoles of glucose added and dividing this figure by the c. p. m. in the labelled glucose added whose radioactivity was determined under the same conditions but in the absence of sodium sulphate.
Measurement of oxygen uptake: Oxygen uptake was measured as described by Nigam (1966) . Samples were pre-incubated in the presence or absence of epinephrine and glucose solution was contained in the side arm. Measurements of oxygen con¬ sumption were made before and after the addition of glucose. Nigam (1966) , AMP according to Adams (1963) (Wu 1964) , and higher glucose 6-phosphate to fructose diphosphate ratio (Wu 1964 ) on epinephrine addition were indicative of an inhibition of phosphofructokinase. (Nigam 1967<7,¿>) . The effect of epinephrine on specific enzymes of glycogen pathway can thereby be ascertained when various precursors of glycogen are incubated with intact aged tumour cells in the presence of epinephrine. Table 2 shows the amount of glycogen synthesised and lactate produced from glucose-6-phosphate, glucose 1-phosphate and UDPglucose by both freshly prepared and aged cells in the presence and absence of 2 10~5 epinephrine. Epinephrine stimulated glycogen synthesis slightly from both glucose and glucose 1-phos¬ phate. On the other hand, glycogen synthesis from glucose 6-phosphate was slightly decreased. When UDPglucose was used as the glycogen precursor, epi¬ nephrine stimulated glycogen synthesis both in the absence and presence of glucose 6-phosphate. The extent of increase varied from 5 to 25 per cent. The amount of lactate produced from various substrates in aged cells was high, and no major differences due to epinephrine addition could be observed. crio« of epinephrine on glycogen breakdown Unlike the glycogenolytic action of epinephrine in muscle, tumour cells were insusceptible to its action. Thus, cells in which glycogen has been deposited by prior incubation with glucose-1-I4C (and free glucose removed by washing the cells), showed no increased disappearance of label from glycogen on further incubation in the presence of epinephrine (Table 3) . On the contrary at higher concentrations (1 mM) of epinephrine there was inhibition in the removal of glycogen label as compared to the control (not shown). Addition of dinitro¬ phenol accomplished rapid breakdown of glycogen, due to increase in AMP concentration required for activation of phosphorylase b (Nigam 1967a ). Cyclic AMP (1 mM) and 5'-AMP (1 ium) also decreased glycogen label but were not as effective as DNP (Table 3) .
DISCUSSION
Ineffectiveness of epinephrine to induce major alteration in glucose and glyco¬ gen metabolism of Novikoff ascites-hepatoma cells provides an instance where neoplastic transformation results in the abolition of hormonal response. The absence of glycogenolytic action of epinephrine in Novikoff ascites-hepatoma (Mayer et al. 1967 ). Indeed, determinations of phosphorylase a and glucose 6-phosphate independent form of UDPglucose-a-glucan glucosyltransferase activities in tumour cell homogenates before and after incubation with epi¬ nephrine show only minor variations in the activities of the two enzymes due to epinephrine. Since the changes induced by epinephrine on glycogen meta¬ bolism of tumour cells are themselves very small, it is not unusual that signi¬ ficant changes in activities of these enzymes were not detected.
The observed data on glucose 6-phosphate and AMP concentration in the tumour cell would normally support that conditions after epinephrine addition are favourable to the activation of UDPglucose-a-glucan glucosyltransferase and inhibition of phosphorylase (Fridland Se Nigam 1965) , except for the fact that epinephrine increases glycogen synthesis from UDPglucose even in the presence of glucose 6-phosphate (Table 2) . Karpatkin et al. (1964) have also observed that although epinephrine induces loss in glycogen and increase in glucose 6-phosphate concentration in frog muscle, there is no activation of UDPglucose-a-glucan glucosyltransferase by accumulated glucose 6-phosphate so that glycogen could be rebuilt from its precursors. Indeed Craig Sc Lamer (1964) have shown that epinephrine mediated decrease in UDP-glucose-aglucan glucosyltransferase activity of rat diaphragm results from a loss of both the glucose 6-phosphate dependent and independent forms of the enzyme.
The effect of epinephrine on phosphorylase has been shown to be mediated by cyclic AMP (Robinson et al. 1967) . Cyclic AMP also diminishes the glucose 6-phosphate dependent and independent activities of UDPglucose-a-glucan glucosyltransferase (Belocopilow 1961 
